01 Rising Incidence of Cerebral Aneurysms and Neurovascular Disorders The major factor driving the growth of flow diverter market is rising incidence of cerebral aneurysms and neurovascular disorders across the globe.In addition, availability of advanced diagnostic technologies such as such as magnetic resonance imaging (MRI) and computed tomography (CT), have increased the detection rates of neurovascular disorders, thus enhanced detection rates propel the demand of flow diverters. Further, rising awareness about cerebral aneurysms and available treatment options among patients and healthcare professionals contributes to increasing diagnosis rates. Furthermore, the major factors such as hypertension, smoking & high alcohol consumption increase the chances of aneurysm formation and rupture, directly impacting the incidence of cerebral aneurysms. Moreover, aged people are at major risk of developing cerebral aneurysm due to weaking of blood vessels in the brain, thereby increasing the likelihood of aneurysm formation. Thus, all above factors are anticipated to drive the demand of flow diverters and further propelling the market expansion.
02 Technological Advancements in Medical Devices Another factor driving the growth of flow diverter market is technological advancements leading to the development of more sophisticated and safer flow diverters. These advancements include use of improved materials, better design, and enhanced delivery systems, resulting in devices that offer higher efficacy and safety profiles. For example, Medtronic offers Pipeline Flex embolization device with Shield Technology, an advanced flow diverter for treating intracranial aneurysms more effectively and safely. The device has shield technology which is a surface modification designed to enhance the device’s biocompatibility and also, reduces the likelihood of thrombus formation on the device surface, thereby minimizing the risk of in-stent thrombosis, a common complication associated with flow diverter implants. Thus, availability of such advanced device with shield technology address key challenges in the traditional device and significantly impacts the flow diverters market growth. The enhanced safety profile, driven by shield technology, increases device's acceptance among healthcare providers, and are more confident in its use for a broader range of patients, including those with complex aneurysms. Thus, such technological innovations are expected to fuel the adoption and growth of flow diverter market revenue.
01 High Cost of Flow Diverter Procedures A major barrier to the growth of the flow diverters market is the high cost involved in the procedures. Despite the possibility for substantial growth, the flow diverters market faces significant challenges, primarily because of the high costs associated with these treatments. The expenses associated with the equipment and the required surgical operations are steep, posing challenges for numerous patients, especially those in areas with constrained healthcare budgets or insufficient insurance coverage. For example, research on the expenses related to endovascular treatment for unruptured intracranial aneurysms in Mexico revealed that the typical expense of the treatment was $21,687.22 USD, with prices fluctuating depending on the aneurysm's location. These elevated costs not only restrict access for patients but also burden healthcare systems, particularly in developing nations.
01 Development of Bioabsorbable Flow Diverters Developing bioabsorbable flow diverters offers lucrative opportunities for key stakeholders in the flow diverter market. Bioabsorbable flow diverters are designed to degrade slowly and absorbed by the body over time, thus eliminating the need for permanent implants and minimizing the risk for long-term complications due to foreign materials in the bloodstream. Further, as these diverters degrade, they stimulate endothelialisation, promoting the formation of a new layer of endothelial cells over the aneurysm neck. Therefore, such natural healing process of bioabsorbable diverters helps to seal off the cerebral aneurysm, preventing future rupture and reducing the risk of recurrence. Further, these diverters mimic like the body's natural healing mechanisms, thereby increasing improved patient outcomes and enhanced safety compared to traditional flow diverter.Furthermore, bioabsorbable flow diverters have the potential to diminish the necessity for follow-up procedures, offering a more convenient and cost-effective solution for patients and healthcare providers. Unlike in the case of permanent implants, which require surgical removal once they have served their purpose, bioabsorbable flow diverters gradually degrade and are replaced by native tissue, without leaving behind any remnant of a foreign body in the fully restored blood vessel. Moreover, companies are developing bioabsorbable flow diverters for treating cerebral aneurysm. For example, as per the press release of Fluid Biomed Inc., in September 2023, reported that, company is commercializing first polymer-based brain stent to cure aneurysms. This flow diverter is composed of dissolving polymer and metal to allow better healing and visualization of blood vessels. Thus, such developments provide key opportunity to the players of the flow diverter market.
02 Expanding Elderly Population & Increasing Prevalence of Hypertension The expanding elderly population across the globe offers significant opportunities to the key players of the flow diverter market. Elderly people are more prone to neurovascular disorders such as cerebral aneurysms due to age-related changes in blood vessels.Further, people suffering from hypertension is a major risk factor for the development, enlargement, and rupture of cerebral aneurysms. Hypertensive people cause hemodynamic stress and inflammation in arterial walls, leading to potential aneurysm formation and rupture. Thus, as more people are diagnosed with hypertension, the chances of aneurysms are more, which drives the demand of flow diverter. Thus, expanding elderly population and rising incidences of hypertension underscores the need for effective treatment options like flow diverters, presenting a significant opportunity for flow diverter market expansion.
April 2026 Stryker strengthened its hemorrhagic stroke portfolio by expanding the availability of advanced flow diverter devices designed to improve procedural precision and long-term treatment outcomes in neurovascular interventions.
February 2026 MicroVention, Inc. expanded its neuroendovascular product portfolio by launching new flow diverter systems featuring optimized mesh design and enhanced navigability for minimally invasive aneurysm treatment.
September 2025 Balt Group introduced upgraded flow diverter devices with improved flexibility and deployment characteristics, supporting the treatment of wide-neck and complex intracranial aneurysms.
May 2025 Terumo Corporation strengthened its neurovascular business by expanding its flow diversion solutions and physician training programs to support the growing adoption of minimally invasive aneurysm treatment technologies.